Cannabis in 2026 – Part II: Hemp Tightening in 2026—The Compliance Cliff, CBD Carve-Out Signals, and Business Risk

[#item_full_content] While federal marijuana policy trends toward less restrictive treatment, hemp faces a sharp regulatory contraction. Late 2025 legislation narrowed what qualifies as lawful hemp and squarely targeted intoxicating hemp-derived products—setting up what many in the industry view as a high-impact compliance and commercial “cliff” in 2026. For hemp brands, retailers, manufacturers, and ancillary partners, the immediate issue is not theory: it is whether current product portfolios, contracts, and distribution channels remain viable under the new federal definition and potency limits.  Read More